Categories Earnings, Health Care

Bio-Path Holdings, Inc. (NASDAQ: BPTH): Q3 2019 Earnings Snapshot

— Bio-Path Holdings, Inc. (NASDAQ: BPTH) reported a net loss of $2.2 million or $0.78 share for the third quarter of 2019, vs. $0.74 per share loss expected.

— Research and development expenses decreased to $1.4 million from $2.3 million last year

— General and administrative expenses were $0.9 million during the three-month period, up 29% from last year

— Recorded cash of $15.4 million as of September 30, 2019, compared to $1.0 million at December 31, 2018

— Net cash used in operating activities was $6.1 million during the nine-month period ended September, compared to $4.8 million last year

— Recently, appointed Martina Molsbergen, chief executive officer of C14 Consulting, to the board of directors of Bio-Path

Listen to publicly listed companies’ earnings conference calls along with the edited closed caption text

Most Popular

Micron Technology (MU) Q3 Earnings: Key financials and quarterly highlights

Micron Technology Inc. (NASDAQ: MU) reported third quarter 2022 earnings results today. Revenue increased 16% year-over-year to $8.64 billion. GAAP net income was $2.63 billion, or $2.34 per share, compared

Constellation Brands (STZ): Earnings beat and share structure revamp put brewer in the spotlight

Shares of Constellation Brands Inc. (NYSE: STZ) were down 4% on Thursday despite the company beating expectations on its first quarter 2023 earnings results. The stock has dropped 7% year-to-date.

Infographic: Key highlights from Constellation Brands (STZ) Q1 2023 earnings results

Constellation Brands, Inc. (NYSE: STZ) reported first quarter 2023 earnings results today. Net sales increased 17% year-over-year to $2.3 billion. Net income attributable to CBI was $390 million, or $2.06

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top